Abstract. Conversion factors, which relate the kerma-area product to effective dose, have been estimated for paediatric cardiac x-ray angiography. Monte Carlo techniques have been used to calculate the conversion factors for a wide range of projection angles for children of five ages and for adults. Correction factors are provided so that the conversion factors can be adjusted for different tube potentials and filtrations.
Introduction
In children with congenital heart disease, x-ray fluoroscopy and cine-fluorography are used for most interventional and many diagnostic procedures. These can be high-dose procedures and there is thus an appreciable risk of radiation-induced detriment. This risk is higher for children than for adults at the same dose level (Stather et al 1988) .
In order to assess the radiation risk during cardiac catheterization, knowledge of the effective dose is required (ICRP 1991) . This quantity is difficult to measure directly and conversion factors must therefore be employed which relate effective dose to measurable quantities such as entrance dose or kerma-area product (often referred to as dose-area product). When beam direction and field size are changing throughout the procedure, the latter quantity is much preferred. Kerma-area product (KAP) to effective dose conversion factors may be obtained by measurement or Monte Carlo calculations, but in situations where data are required for many different configurations, Monte Carlo studies are the only practicable approach.
For adult cardiology, conversion factors have been published for limited projections by Hart et al (1994) and doses have been published for selected organs by Stern et al (1995) . However, there is no tabulation of KAP to effective dose conversion factors for paediatric cardiac angiography currently available. The objective of this paper, therefore, is to provide a comprehensive set of KAP to effective dose conversion factors applicable to a wide range of patient sizes and imaging geometries for paediatric cardiology. For completeness, the corresponding conversion factors for adults have also been calculated.
Methods

Monte Carlo program
The Monte Carlo program employed for the dose calculations was developed by Tapiovaara et al (1997) (PCXMC, version 1.3) and is commercially available. X-ray projections, patient 0031-9155/00/103095+13$30.00 © 2000 IOP Publishing Ltd sizes and x-ray spectra are freely adjustable. Users can specify the x-ray spectrum by choosing the target angle, tube potential and filtration. The dimension of the rectangular radiation field, the projection angle, patient age and size are required as input. The program calculates organ doses and effective dose for a given skin entrance dose or kerma-area product.
In the present work, each calculation was based on generating 30 000 photons. The relative statistical errors on the conversion factors were then less than 2%. Tapiovaara et al (1997) have validated the program for a range of x-ray projections and patient sizes by comparing effective and organ doses and conversion factors with values calculated by Hart et al (1994 Hart et al ( , 1995 .
Patient model
The patient model used in the PCXMC Monte Carlo program is based on the mathematical hermaphrodite body phantoms developed by Cristy and Eckerman (1980) . Using these phantoms, six default patient sizes were available ranging from neonate to adult. The heart model used in the Cristy phantom is rather complex, and for the purpose of determining the radiation field size, the heart was treated as a sphere, with a diameter equal to the maximal dimension of the heart according to the Cristy model. The diameter was increased by 1.5 cm to provide a clearance margin. Table 1 gives the size of the radiation field and other important parameters for the six phantom sizes studied.
For all Monte Carlo calculations, the arms were removed from the body phantom, leaving a reduced trunk width. This simulates the normal clinical practice where the arms are raised out of the x-ray beam.
PCXMC geometry
The complex projections used in cardiology are defined in terms of rotation of the image intensifier/x-ray tube and the gantry. The axes of rotation are not the same as those used by the Monte Carlo program, and the relationship between the two geometries must therefore be established. For the Monte Carlo program the geometry is defined as follows:
• (X, Y, Z): the coordinate system used by Cristy and Eckerman (1980) and the PCXMC program, which we call the body coordinate system. The origin is located at the bottom of the trunk with the Z-axis pointing towards the head, the X-axis pointing to the left and the Y -axis pointing towards the back. As the patient is examined supine, the Z-axis points along the couch top and the Y -axis vertically downwards.
: the position vector of the heart centre in the body coordinate system.
• (x, y, z): the isocentric coordinate system. This is a coordinate system parallel to (X, Y, Z) and obtained by a translation to the isocentre of the x-ray unit, which is assumed to be the centre of the heart. The z-and y-axis of the isocentre coordinate system are shown. The heart (black circle) is at the origin of that coordinate system.
• r fsd : x-ray field size at skin level.
• d fsd : focus-skin distance.
• d if : focus isocentre distance. This has been fixed at 70 cm for all cases considered here.
• : angle between the (X, Y ) plane and the central axis of the x-ray beam. This angle is positive when the x-ray tube is tilted towards the head and negative when it is tilted towards the feet.
• : azimuthal angle of the central axis of the x-ray beam. This is the angle between the X-axis and the projection of the position vector of the x-ray focus onto the (X, Y ) plane.
Imaging geometry
It should be noted that the names used for projections in cardiac x-ray imaging are the reverse of those used in other areas of radiology. In this paper the cardiological terminology has been adopted. In biplanar cardiac imaging the two x-ray tubes may be referred to as frontal and lateral tubes. With this terminology the cardiac imaging geometry may be defined as follows:
• A-plane: the x-ray projection produced by irradiation using the frontal x-ray tube. The orientation of this plane is controlled by rotation about two axes (defined below). In the unrotated position, the x-ray tube is under the couch and the central ray of the x-ray beam points vertically upwards and through the isocentre. In cardiology this is called an anterior-posterior (AP) projection (figure 1).
• B-plane: the x-ray projection produced by irradiation using the lateral x-ray tube. The orientation of this plane is controlled by rotation about two axes (defined below). In the unrotated position, the x-ray tube is on the right of the patient and the central ray of the x-ray beam points horizontally and through the isocentre. In cardiology this is called a left lateral projection (figure 2).
• ϕ A,B : oblique angles specifying the positions of the two image intensifiers after rotation about the z-axis (first rotation). For A or B plane rotations, both angles are defined in relation to the A-plane unrotated position. For a left anterior oblique (LAO), the image intensifier is rotated to the patient's left and the angle is positive. For a right anterior oblique (RAO), the image intensifier is rotated to the patient's right and the angle is negative. Therefore, an AP view corresponds to LAO 0 • and a left lateral view (LAT) to LAO 90
• .
• (x , y , z ): the intermediate A-plane coordinate system. This is a coordinate system centred on the isocentre and defined in relation to the A-plane of the x-ray unit when the second A-plane rotation is zero. The z -axis is coincident with the z-axis. The xand y -axes are obtained by rotating the x-and y-axes about the z-axis through the first A-plane rotation angle to reach oblique angle ϕ A .
• ϑ A : second A-plane rotation angle. This corresponds to a rotation about the x -axis in the intermediate A-plane coordinate system. It gives a cranial (image intensifier towards the head of the patient) or caudal tilt. The angle is positive and negative for cranial and caudal tilts respectively.
• ϑ B : second B-plane rotation angle. This corresponds to a rotation about the y-axis in the isocentric coordinate system. It gives a cranial (image intensifier towards the head of the patient) or caudal tilt. The angle is positive and negative for cranial and caudal tilts respectively. Because of the use of different rotation axes, ϑ A and ϑ B are not simply related.
• d is : isocentre-skin distance.
• r h : field size at isocentre (see table 1 ).
The angles ϕ A,B , ϑ A , ϑ B are related to the angles of rotation in PCXMC and by applying the following formulae:
• A-plane:
• B-plane:
The radiation field size r fsd at the skin can be calculated from the field sizes at the isocentre and knowledge of d is and d if . The distance d is may be computed from the intersection of the central beam axis with the Cristy phantom, which in the relevant region is an elliptical cylinder. For the Monte Carlo calculation square fields were used.
Systematic errors and sensitivity of conversion factors to choice of model
Systematic errors in the conversion factors can arise through the choice of all input parameters in the model. These include the photon interaction cross sections and organ compositions and density. In addition, body compositions are assumed to be constant within each organ and certain approximations are made in dealing with the dose to active bone marrow. As a commercially available program has been used, it is not possible to make a detailed study of the effect of changes in all of these parameters on the results. However, by scaling all linear dimensions of the model and radiation field by the same amount and adjusting the mass of the phantom as appropriate, it is possible to simulate the effect of changing the cross sections or tissue densities on the conversion factor. In this way the effect of changes of 2% in interaction cross sections or tissue density have been estimated. The uncertainty of 2% (one standard deviation) is that stated by Hubbell (1999) for current compilations of total cross sections. Density uncertainties are unknown, but an uncertainty of 2% is used for illustrative purposes. The uncertainty arising from the modelling of the energy deposited in the active bone marrow is more difficult to estimate, but a maximal estimate has been derived from the contribution of the dose to active bone marrow to the total effective dose. In addition to the systematic errors due to the calculations for a particular geometric model of the patient and radiation field, there will be errors because the model and field placements do not actually correspond to those for any particular patient. The effective dose conversion factors can in principle depend strongly on the choice of phantom, organ positions within the phantom, field size and position. A small change in field size or the position of an organ can produce important changes in conversion factors. These effects have been studied in two ways. Firstly, the conversion factors have been recalculated for selected cases for field sizes decreased and increased by 1 cm. Secondly, the conversion factors have been compared with results from two other studies (Hart et al 1994 , Stern et al 1995 . Both of these studies present conversion factors from Monte Carlo calculation based on body phantoms similar to those used by PCXMC (Tapiovaara et al 1997) .
Choice of x-ray spectra and projection angles
The conversion factors have been calculated for a range of x-ray spectra and projection angles. For the majority of cases the spectra were modelled on typical values used for paediatric cardiac catheterizations in the cardiac unit at the Royal Brompton Hospital and used the following parameters: target angle 8
• , peak voltage 65 kV and filtration 3 mm aluminium (Al). To facilitate dose estimates for other x-ray spectra, calculations have been made in selected cases for tube potentials between 60 kVp and 80 kVp and filtrations of 2.5 mm Al and 3.5 mm Al at 65 kVp. In addition, conversion factors have been calculated for 2.5 mm Al, 3.0 mm Al and 3.5 mm Al at 65 kVp with an extra 0.1 mm Cu filter.
Projections
Conversion factors were calculated in the angular range between RAO 45
• and LAO 75
• for the A-plane and between LAT (LAO 90
• ) and LAO 45
• for the B-plane. For each A-and B-plane projection, tilts between caudal 45
• and cranial 45
• were also taken into account. The calculations were performed at 15
• intervals for both LAO/RAO and caudal/cranial angles. This amounts to 91 angular projections for each age. Hart et al (1994) 
Results and discussion
Study of systematic errors and the sensitivity of the results to the choice of model parameters
3.1.1. Systematic errors. The conversion factors for the neonate and the 5-year-old child have been calculated for AP, LAT and LAO 30 Cran 30 projections in the A-plane to simulate the effect of changing the cross sections or density by 2%. The maximum change in the conversion factor corresponding to a change in cross section of 2% was found to be 4% (for the neonate examined with the LAT field) and the maximum change due to a change in density of 2% was 2%. It is stressed that these results are for this particular imaging situation and will change for other radiological examinations, where the organs contributing significantly to the effective dose will be different and at different positions in the field.
The accurate computation of the dose to the active bone marrow in Monte Carlo simulations is difficult and the PCXMC program makes some (necessary) simplifying assumptions. Tapiovaara et al (1997) used a dose enhancement factor to allow for the effects of bone cavities. The same factors are used for all ages and bones. We have estimated that this causes a systematic error of no more than 10% in the dose to the active bone marrow. For the configurations investigated in this work the dose to the active bone marrow contributes no more than 20% to the total effective dose. It is estimated therefore that uncertainties in the modelling of the active bone marrow contribute a systematic error of less than 2% in the total effective dose.
There are other aspects of the model which it has not been possible to vary (such as the shape of the differential cross section and the tissue compositions within particular organs). Nevertheless, if the above contributions are combined in quadrature, an approximate estimate of the systematic uncertainty in the calculation of the conversion factors for a given geometric model can be made, which is 5% (one standard deviation).
Variation of conversion factor with field size.
The conversion factors for the neonate and the 5-year-old child have been calculated for AP, LAT and LAO 30 Cran 30 projections in the A-plane with field sizes increased and decreased by 1 cm from those given in table 1. The change in conversion factor varies with age and projection. For the reduced field size, it is largest in the AP projection where it is 13% and 10% for the neonate and 5-year-old child respectively. When the field size increases by 1 cm, the maximum change in conversion factor for the neonate is 11% (LAT projection) and for the 5-year-old is 8% (AP projection). Hart et al (1994) . Hart et al (1994) used the same body phantom as PCXMC (Tapiovaara et al 1997) . It gives conversion factors for just a limited set of projections: AP, PA, mLAT (mean value of right and left lateral), LAO 45 and RAO 45. For comparison purposes the field sizes and target angle (17 • ) used in PCXMC were modelled after the values used by Hart et al (1994) . Table 2 shows the Hart et al (1994) and PCXMC results for two tube potentials common in paediatric angiography: 60 kVp and 70 kVp. As can be seen from the table, the values computed by PCXMC compare well (within 10% to 20%) with the Hart et al (1994) data. A similar level of agreement was obtained by Tapiovaara et al (1997) . The main reason for the discrepancies is a different configuration for the oesophagus, which is not included in the original Cristy model (Cristy and Eckerman 1980) and was added by the authors of the Hart et al (1994) and PCXMC model. Stern et al (1995) . Stern et al (1995) listed selected organ doses for a series of common cardiac projections for 1 Gy entrance air kerma (free-in-air at entrance surface). Doses were calculated using separate adult male and female phantoms for circular radiation fields. For comparison purposes, in PCXMC they were approximated by taking a square field of the same area. The x-ray spectra were matched on the basis of the half-value layer (HVL). Effective doses have been compared for three tube potentials and for both the male and female phantoms. The effective dose is not given in the Stern et al (1995) report. In order to compare the results with PCXMC, a 'reduced effective dose' has been estimated by taking just the data for organs listed by Stern et al (1995) into account. This ignored the remaining organs (as defined in ICRP (1991)) and the skin and bone surface. The contribution of missing organs to the total effective dose was always less than 10%.
Comparison with data from
To illustrate the differences between the two methods, figures 3 and 4 show the 'reduced effective dose' for a female adult phantom at HVL 3.5 mm Al (figure 3) and a male adult phantom at HVL 4.0 mm Al (figure 4) for a representative range of projections. Despite differences in the body phantom, the doses from the two Monte Carlo models agree well, with most differences between 10% and 20%. Similar results were obtained when comparing the 'reduced effective doses' for other HVL values. Table 6 . KAP to effective dose conversion factors (mSv Gy −1 cm −2 ) for selected projection angles for 10-year-olds.
Cran 45 
Discussion
It has been shown above that the systematic error for computation using a particular model is of the order of 5% and that variations between quite similar geometrical models give rise to differences of 10-20% in the conversion factor. Even bigger changes can be expected when comparing with values for real patients and real radiation fields, because of the variability of the human anatomy, field placement and size (Wise et al 1999) . However, in general, it is not yet practical to customize individual calculations. The use of estimated conversion factors using simple geometric models remains the most practical solution to the problem of dose estimation in the majority of situations. Figures 5 and 6 show the dependence of the conversion factor on projection angle for a 5-year-old. It can be seen that for fixed oblique angle and the data plotted in figure 5 , the variation with cranio-caudal angle between neighbouring data points is sufficiently small for interpolation purposes (below 20%). This is true in general, but in a few cases the differences may be up to a factor of 2. For fixed cranio-caudal angle (figure 6), the variation with oblique angle between neighbouring data points is, again, sufficiently small for interpolation purposes (below 20%). As above, this generally holds for most angles. The variation between tabulated data points is due to differences in field size, x-ray path length and organs directly exposed. Linear interpolation between neighbouring angles is adequate for practical purposes but the use of the closest tabulated data point can also be considered as linear interpolation cannot take into account changes of the organs within the field of view. Figure 7 shows the dependence of the conversion factor on age for three representative projections: AP, LAT and A-LAO 30 Cran 30. On the basis of these results, it is suggested that interpolation in the logarithm of the conversion factor is used for intermediate ages. Similar logarithmic interpolation could also be used to obtain conversion factors for intermediate patient sizes. 
Conversion factors
Conversion factors for different x-ray spectra
Relative conversion factors at 60, 65, 70, 75 and 80 kVp with 3 mm Al filtration for the six ages and three representative projection angles (A-LAO 30 Cran 30, LAT and AP) are given in tables 9 to 11. In each case, the conversion factors have been normalized to the value for 65 kV, which may be found in tables 3 to 8. The variation of the relative conversion factor with tube voltage is approximately linear. In addition, its variation with patient age for fixed projection and tube voltage and its variation with projection for fixed patient age and tube voltage are both small (less than 2% between neighbouring points).
Relative conversion factors at 65 kVp with 2.5, 3.0 and 3.5 mm Al filtration and 2.5, 3.0, 3.5 mm Al filtration plus 0.1 mm Cu for three ages and three representative projection angles (A-LAO 30 Cran 30, LAT and AP) are given in table 12. In each case, the conversion factors have been normalized to the value for 65 kV 3 mm Al, which may be found in tables 3, 5 and 6. For changes in aluminium filtration (table 12), the variation in the relative conversion factor with filter thickness is about 11% mm −1 and has only a small dependence on projection and patient age. The effect of adding 0.1 mm Cu filtration (table 12) is to increase the relative conversion factor by about 30%. With this amount of Cu added, the variation of the relative conversion factor with Al filter thickness is about 5% mm −1 and again there is only a small dependence on projection and patient age. 
Conclusions
Conversion factors for the estimation of effective dose from kerma-area product have been calculated for a wide range of paediatric and adult cardiac x-ray angiography imaging parameters. The factors vary significantly with the different parameters considered, but the tabulated results for 91 projections and six patient ages (tables 3-8) allow adequate interpolation for a standard x-ray spectrum of 65 kVp with 3 mm of Al filtration. Relative conversion factors for other tube voltages and added filtrations show only a small dependence on patient age and projection and may be used to extend the conversion factors for the standard spectrum to other tube voltages and filtrations.
